www.alk.net
  • Patients
    • What is allergy
      • House dust mite allergy
      •  
      • Pollen allergy
      •  
      • Living with allergy
      •  
      • Socio-economic impact
      •  
    •  
    • What is allergic asthma
    •  
    • How is allergy diagnosed
    •  
    • Treating allergy
    •  
  •  
  • Healthcare Professionals
    • Treating allergy and asthma
    •  
    • Products
    •  
    • Adverse reactions
    •  
    • Initiation of treatment
    •  
    • Clinical trials
    •  
  •  
  • R&D
    • R&D pipeline
    •  
    • Understanding immunotherapy
    •  
    • Research
    •  
    • Congress activities
    •  
    • Clinical data sharing
    •  
  •  
  • Careers
    • Working at ALK
    •  
    • Vacant positions
    •  
  •  
  • Investors
    • Overview
    •  
    • Financial reporting
      • Risk management
      •  
      • Reporting standards
      •  
      • Auditors
      •  
    •  
    • Governance
      • IR policy
      •  
      • Management
      •  
      • Board of directors
      •  
      • Annual general meeting
      •  
      • Annual general meeting (DK)
      •  
    •  
    • News & Events
      • Company Releases
      •  
      • Company releases (DK)
      •  
      • Webcasts & presentations
      •  
      • Investor calendar
      •  
    •  
    • The Share
      • Dividend history
      •  
      • Analyst coverage
      •  
      • Analyst estimates
      •  
      • Shareholder information
      •  
      • Authorizations
      •  
      • ADR Programme
      •  
    •  
    • Contact IR
    •  
    • Management
    •  
    • Board of directors
    •  
    • AGM
    •  
    • AGM (DK)
    •  
    • Nyheder
    •  
    • Nyheder (EN)
    •  
  •  
  • Media
  •  
  • About
    • ALK at a glance
    •  
    • CSR
    •  
    • Production
    •  
    • Global presence
    •  
    • Organisation
    •  
    • History
    •  
    • Values
    •  
    • Owners
    •  
  •  
  • Select country
  •  
Search

Investors

The Share

See all

 


Company releases

See all

  • Post date: 03/26/21
    Grant of share options and performance shares to members of the Board of Management and key employees
    Read more
  • Post date: 03/18/21
    Annual General Meeting in ALK-Abelló A/S held on 18 March 2021
    Read more
  • Post date: 02/23/21
    Annual General Meeting in ALK-Abelló A/S on 18 March 2021
    Read more
  • Post date: 02/10/21
    ALK releases 2020 annual report
    Read more
  • Post date: 02/04/21
    Release date of annual report 2020 for ALK and audio cast
    Read more
  • Post date: 12/17/20
    ALK – Financial calendar for the 2021 financial year
    Read more

Featured Events
Mar 18, 2021
Annual General Meeting 2021
Presentation
Præsentation

Written requests to have specific business transacted at the AGM will be included in the agenda if received by the company on 3 February 2021 at the latest (may be e-mailed to investor@alk.net)

 

Se generalforsamlingen her

https://live.axion.dk/alk/210318/dk/kjh81Gw.html


View the AGM here

https://live.axion.dk/alk/210318/uk/oiy634sd.html


Read more
Upcoming Events
May 5, 2021
Three-month interim report (Q1) 2021
May 7, 2021
Virtual Copenhagen roadshow
May 12, 2021
Virtual London & Scotland roadshow

Read more

Annual report 2020

Read more

 

AGM/Generalforsamling

Read more

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved